21ENGBIO A Universal and Controllable Interface between Synthetic Cells and Living Cells

21ENGBIO 合成细胞和活细胞之间的通用且可控的接口

基本信息

  • 批准号:
    BB/W011468/1
  • 负责人:
  • 金额:
    $ 12.84万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2023
  • 资助国家:
    英国
  • 起止时间:
    2023 至 无数据
  • 项目状态:
    已结题

项目摘要

A growing area of research is the creation of 'synthetic cells' from discrete building blocks. Through this research we can gain an understanding of how life started and evolved. Additionally, as synthetic cells are completely modular and cannot self-replicate, they offer promise as novel drug delivery systems and as tools to interface living and non-living materials. These interfaces might be used to study or modify living tissue, without the need for genetic modification. Approaches to interface synthetic cells with living cells often arise from mimicking specific processes in living cells, without other competing processes. However, currently there are no universal methods to allow synthetic cells to communicate with living cells using a wide range of signal molecules. For instance, the two most common approaches rely on identifying signal molecules that will move across the synthetic cell membrane by themselves, or the use of proteins that form holes in the membranes. However, beyond not being universal, both approaches have significant downsides and limitations. We will generate a method that allows the release of any-sized signal molecule. This will be a step change in the use of synthetic cells as research tools and drug delivery devices. Our approach will mimic the communication of neurons in the brain. Neurotransmitters are held within neurons in small compartments. Release of neurotransmitters at the synapse is achieved by the fusion of these small compartments to the cell membrane, by forcing them together. We will generate synthetic cells that contain small compartments. These small compartments will be able to be filled with any-sized signal molecule. Fusion of the small compartment to the synthetic cell membrane, like is seen in neurons, will be initiated by using a mix of DNA and RNA strands. DNA and RNA complementarity is ideal for this function as it is strong and programmable. By incorporating functional signal molecules within the small compartments, we will then interface these synthetic cells with neighbouring living cells to control their function.For real world application, the function of synthetic cells needs to be triggered, ideally with a remote stimulus, to inhibit the synthetic cell activity where it is not wanted. Light is an ideal stimulus as it can be applied remotely at a precise point in space and time. To achieve this, we will incorporate a light-activated template that the synthetic cells with function from, which we have previously generated.Our method to interface synthetic and living cells will be universal and remote controllable. By encapsulating neurotransmitters within the small compartments, this externally controlled release might be used as a computer-brain interface between synthetic cells and neurons. Additionally, as any molecule could be encapsuled in the synthetic organelles and released with light, there is the potential for precision drug targeting to any living cell. This basic research project to broaden the functionality of synthetic cells has the potential to revolutionise the research area and bring about the real-world potential of synthetic cells.
不断增长的研究领域是从离散构建块创建“合成细胞”。通过这项研究,我们可以了解生活的开始和发展。此外,由于合成细胞是完全模块化的,并且不能自我复制,因此它们作为新型药物输送系统和界面生活和非生存材料的工具提供了希望。这些界面可用于研究或修饰活组织,而无需遗传修饰。与活细胞合成细胞界面合成细胞的方法通常是由于模仿活细胞中的特定过程而没有其他竞争过程。但是,目前尚无通用方法,可以使用多种信号分子与活细胞与活细胞进行通信。例如,这两种最常见的方法依赖于识别信号分子,这些信号分子本身会在合成细胞膜上移动,或者使用在膜中形成孔的蛋白质。但是,除了没有普遍性外,这两种方法都具有明显的弊端和局限性。我们将生成一种允许释放任何大小信号分子的方法。这将是使用合成细胞作为研究工具和药物输送设备的步骤变化。我们的方法将模仿大脑中神经元的交流。神经递质在小隔室的神经元内举行。神经递质在突触中的释放是通过将这些小隔室融合到细胞膜来实现的。我们将生成包含小隔室的合成细胞。这些小隔室将能够用任何大小的信号分子填充。小室与合成细胞膜的融合(如在神经元中所见)将通过使用DNA和RNA链的混合物来启动。 DNA和RNA互补性是此功能的理想选择,因为它是强大且可编程的。通过将功能信号分子纳入小隔室,我们将与邻近活细胞连接这些合成细胞以控制其功能。对于现实世界的应用,需要触发合成细胞的功能,理想地使用远程刺激,以在不需要的情况下抑制合成细胞活性。光是一种理想的刺激,因为它可以在空间和时间的精确点上远程应用。为了实现这一目标,我们将结合一个带有功能的合成细胞与以前生成的光激活模板。我们的接口合成方法和活细胞的方法将是通用且遥控的。通过将神经递质封装在小室内,该外部控制释放可以用作合成细胞和神经元之间的计算机脑接口。此外,由于任何分子都可以封装在合成细胞器中并用光释放,因此有可能将药物靶向任何活细胞。这项扩大合成细胞功能的基础研究项目具有彻底改变研究领域并带来合成细胞的现实潜力的潜力。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Engineering cellular communication between light-activated synthetic cells and bacteria.
  • DOI:
    10.1038/s41589-023-01374-7
  • 发表时间:
    2023-09
  • 期刊:
  • 影响因子:
    14.8
  • 作者:
    Smith, Jefferson M.;Hartmann, Denis;Booth, Michael J.
  • 通讯作者:
    Booth, Michael J.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael Booth其他文献

An accountability framework for the financial sustainability of Australian international development organisations
澳大利亚国际发展组织财务可持续性的问责框架
  • DOI:
    10.5204/thesis.eprints.104748
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Michael Booth
  • 通讯作者:
    Michael Booth
The politics of disciplinary advantage
学科优势的政治
  • DOI:
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Steven Rodgers;Michael Booth;J. Eveline
  • 通讯作者:
    J. Eveline
A randomised trial of an intervention to develop health promoting schools in Australia: the south western Sydney study
  • DOI:
    10.1111/j.1467-842x.2000.tb01563.x
  • 发表时间:
    2000-06-01
  • 期刊:
  • 影响因子:
  • 作者:
    Jo Mitchell;Sandra Palmer;Michael Booth;Gawaine Powell Davies
  • 通讯作者:
    Gawaine Powell Davies
Service users being used: thoughts to the research community
正在使用的服务用户:对研究界的思考
Opioid prescriber screening practices to detect risk for developing opioid use disorder: Qualitative perspectives from providers during the fourth wave of the opioid crisis
阿片类药物处方者筛查实践,以检测发生阿片类药物使用障碍的风险:第四波阿片类药物危机期间提供者的定性观点
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    M. Skeer;Yang Jier;Michael Booth;Evan T. Robison;Grace Hajinazarian;Tamar M. Boyadjian;Rachael A Sabelli;K. Chui;T. Stopka
  • 通讯作者:
    T. Stopka

Michael Booth的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael Booth', 18)}}的其他基金

SIGSYNCELL: Engineering biological signaling pathways using synthetic cells
SIGSYNCELL:使用合成细胞工程生物信号通路
  • 批准号:
    EP/Y032675/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.84万
  • 项目类别:
    Research Grant
Controlling cell-free expression with temperature-sensitive polymer-DNA conjugates
使用温度敏感聚合物-DNA 缀合物控制无细胞表达
  • 批准号:
    EP/V030434/2
  • 财政年份:
    2022
  • 资助金额:
    $ 12.84万
  • 项目类别:
    Research Grant
Controlling cell-free expression with temperature-sensitive polymer-DNA conjugates
使用温度敏感聚合物-DNA 缀合物控制无细胞表达
  • 批准号:
    EP/V030434/1
  • 财政年份:
    2021
  • 资助金额:
    $ 12.84万
  • 项目类别:
    Research Grant

相似国自然基金

PD-L1改善通用型干细胞衍生RPE治疗AMD效果的机制研究
  • 批准号:
    82371107
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
利用全基因组关联分析研究抗病杂种优势的普遍遗传机制
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    58 万元
  • 项目类别:
    面上项目
利用全基因组关联分析研究抗病杂种优势的普遍遗传机制
  • 批准号:
    32170292
  • 批准年份:
    2021
  • 资助金额:
    58.00 万元
  • 项目类别:
    面上项目
适用于链霉菌间高效质粒转移的普遍性转导噬菌体的分离与鉴定
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    12.3 万元
  • 项目类别:
    国际(地区)合作与交流项目
VOCs/水蒸气在活性炭中竞争吸附行为的普遍化描述
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    24 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Cosmological hydrodynamical simulations with calibrated non-universal initial mass functions
使用校准的非通用初始质量函数进行宇宙流体动力学模拟
  • 批准号:
    2903298
  • 财政年份:
    2027
  • 资助金额:
    $ 12.84万
  • 项目类别:
    Studentship
CageTag: Caged Theranostics as a Universal Platform for Nuclear Medicine
CageTag:笼式治疗诊断学作为核医学的通用平台
  • 批准号:
    EP/V055836/2
  • 财政年份:
    2024
  • 资助金额:
    $ 12.84万
  • 项目类别:
    Research Grant
CAREER: A Universal Framework for Safety-Aware Data-Driven Control and Estimation
职业:安全意识数据驱动控制和估计的通用框架
  • 批准号:
    2340089
  • 财政年份:
    2024
  • 资助金额:
    $ 12.84万
  • 项目类别:
    Standard Grant
微分幾何学に基づいた非平衡熱力学における普遍的原理の探究
基于微分几何的非平衡热力学普遍原理探索
  • 批准号:
    23K22412
  • 财政年份:
    2024
  • 资助金额:
    $ 12.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
不規則構造体のテラヘルツ帯普遍的励起の分光評価による理解と応用
通过光谱评估理解和应用太赫兹带无序结构的普遍激发
  • 批准号:
    23K25836
  • 财政年份:
    2024
  • 资助金额:
    $ 12.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了